Skip to main content
. 2018 Jun 14;29(7):2000–2013. doi: 10.1681/ASN.2017111185

Table 2.

Significant single-nucleotide polymorphisms, test statistics, and values from the trans-ethnic meta-analysis and conditional analyses

SNP Risk Allele Other Allele Risk AF Meta-Analysis across Cohorts, n=3652 (385 Crossethnic Patients; 3267 Crossethnic Controls) Meta-Analysis, Conditional on rs1063348, n=3652 (385 Crossethnic Patients; 3267 Crossethnic Controls) Meta-Analysis, Conditional on rs1063348 and rs28366266, n=3652 (385 Crossethnic Patients; 3267 Crossethnic Controls)
OR [95% CI] P Value Q Test OR [95% CI] P Value Q Test OR [95% CI] P Value Q Test
rs1063348 (6:32627923) Ga A 0.60 3.33 [2.62 to 4.23] 9.30E−23 0.79
rs28366266 (6:32559753) Ca T 0.17 3.03 [2.40 to 3.85] 4.10E−20 0.09 2.17 [1.73 to 2.74] 3.66E−11 0.36
rs9348883 (6:32358549) Ta A 0.94 2.51 [1.49 to 4.22] 4.70E−04 0.68 2.57 [1.53 to 4.31] 3.40E−04 0.81 3.5 [2.13 to 5.83] 9.40E−07 0.70

Genome-wide association study (GWAS) results for top SNPs of interest: rs1063348, top SNP in meta-analysis across cohorts; rs28366266, top SNP in meta-analysis conditional on rs1063348; and rs9348883, top SNP in meta-analysis conditioned on rs1063348 and rs28366266. For each SNP, we present the GWAS results in the crosspopulation meta-analysis of all individual cohorts taken together (n=3652, including 385 patients and 3267 controls) and the conditional crosspopulation meta-analysis conditioned on rs1063348 alone and then rs1063348 and rs28366266 together. ORs with 95% CIs and P values are reported for each SNP in each analysis. SNP, single-nucleotide polymorphism; AF, allele frequency; OR, odds ratio; 95% CI, 95% confidence interval; —, not tested.

a

Risk allele.